Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.39) per share. This is a 21.88 percent decrease over losses of $(0.32) per share from the same period last year.
Blackboxstocks Outlines Details Of Its Capital Structure, Number Of Free Trading Shares, Public Float
No Insider Sales since Uplisting to Nasdaq on November 10, 2021
DALLAS--(BUSINESS WIRE)-- Blackboxstocks Inc. (NASDAQ:BLBX) (“Blackbox”), a financial technology and social media hybrid platform offering